glp-1 and chronic fatigue syndrome Drugs to Reduce Symptoms in People with ME/CFS Identify Disease Subgroups GLP-1 receptor agonists for ME/CFS?

The characterization of AD as Type 3 diabetes, a condition of brain-specific insulin resistance, has directed attention toward GLP-1 receptor agonists as potential neuroprotective agents (de la Monte and Wands, 2008)

You wake up feeling fine, or at least much better than you would have felt riding out those hours while conscious

Some researchers are exploring whether compounds like AOD-9604 combined with tirzepatide might offer complementary mechanisms without the cardiovascular concerns of stimulant addition

Gallagher PM, Meleady R, Shields DC, Tan KS, McMaster D, Rozen R, Evans A, Graham IM, and Whitehead AS (1996)

Use of GLP-1 RAs is limited by high cost, which creates disparities those who cannot afford these drugs may miss out on the benefits

Rogerson, M